Exploring a novel outcome measure of symptom progression in knee osteoarthritis utilizing a large randomized trial

Conaghan, P.G. orcid.org/0000-0002-3478-5665, Katz, N., Hunter, D.J. et al. (8 more authors) (2025) Exploring a novel outcome measure of symptom progression in knee osteoarthritis utilizing a large randomized trial. Osteoarthritis and Cartilage, 33 (3). pp. 383-390. ISSN 1063-4584

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2024 The Author(s). This is an open access article under the terms of the Creative Commons Attribution License (CC-BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.

Keywords: Osteoarthritis, Knee, Sprifermin, Fibroblast growth factor 18, Treatment outcome
Dates:
  • Published: March 2025
  • Published (online): 27 December 2024
  • Accepted: 12 December 2024
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Musculoskeletal Medicine & Imaging (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 15 Jan 2025 13:59
Last Modified: 06 Mar 2025 13:23
Status: Published
Publisher: Elsevier
Identification Number: 10.1016/j.joca.2024.12.003
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics